Chen YC, Malfertheiner P, Yu HT, Kuo CL, Chang YY, Meng FT, Wu YX, Hsiao JL, Chen MJ, Lin KP, et al. Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology. 2024;166(4):605–19.
Google Scholar
Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2023;8(6):553–64.
Google Scholar
Ahn JY. Prevention of gastric cancer: Helicobacter pylori treatment. Korean J Helicobacter Up Gastrointest Res. 2024;24(3):238–42.
Google Scholar
Sugano K, Suzuki C, Ota M, Iwakiri R. Gastric cancer risk after Helicobacter pylori eradication in gastritis and peptic ulcer: a retrospective cohort study in Japan. BMC Gastroenterol. 2025;25(1): 463.
Google Scholar
Ono A, Tanaka S, Sawada N, Goto A, Tsugane S, Muraki I, Yamagishi K, Sasaki Y, Abe Y, Kayama T, et al. Helicobacter pylori eradication and gastric cancer prevention in a pooled analysis of large-scale cohort studies in Japan. Sci Rep. 2025;15(1): 21307.
Google Scholar
Amrousy DE, Ashry HE, Maher S, Abdelhai D, Hassan S. Helicobacter pylori infection and gut microbiota in adolescents: is there a relation? J Biosci. 2024;49:7.
Google Scholar
Frost F, Kacprowski T, Rühlemann M, Bang C, Franke A, Zimmermann K, Nauck M, Völker U, Völzke H, Biffar R, et al. Helicobacter pylori infection associates with fecal microbiota composition and diversity. Sci Rep. 2019;9(1): 20100.
Google Scholar
Chen CC, Liou JM, Lee YC, Hong TC, El-Omar EM, Wu MS. The interplay between Helicobacter pylori and gastrointestinal microbiota. Gut Microbes. 2021;13(1):1–22.
Google Scholar
Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Dumyati GK, et al. Trends in U.S. burden of clostridioides difficile infection and outcomes. N Engl J Med. 2020;382(14):1320–30.
Google Scholar
Akorful RAA, Odoom A, Awere-Duodu A, Donkor ES. The global burden of clostridioides difficile infections, 2016–2024: a systematic review and meta-analysis. Infect Dis Rep. 2025. https://doi.org/10.3390/idr17020031.
Google Scholar
Fu Y, Luo Y, Grinspan AM. Epidemiology of community-acquired and recurrent clostridioides difficile infection. Ther Adv Gastroenterol. 2021;14: 17562848211016248.
Google Scholar
Bartlett JG. Narrative review: the new epidemic of clostridium difficile-associated enteric disease. Ann Intern Med. 2006;145(10):758–64.
Google Scholar
McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, et al. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):987–94.
Google Scholar
Di Bella S, Sanson G, Monticelli J, Zerbato V, Principe L, Giuffrè M, Pipitone G, Luzzati R. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options. Clin Microbiol Rev. 2024;37(2):e0013523.
Google Scholar
Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107(7):1011–9.
Google Scholar
McDonald EG, Milligan J, Frenette C, Lee TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent clostridium difficile infection. JAMA Intern Med. 2015;175(5):784–91.
Google Scholar
Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, Chiriac SA, Ciobica A, Boiculese L. Proton pump inhibitors therapy and risk of clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol. 2017;23(35):6500–15.
Google Scholar
Kumar S, Metz DC, Kaplan DE, Goldberg DS. Treatment of Helicobacter pylori is not associated with future Clostridium difficile infection. Am J Gastroenterol. 2020;115(5):716–22.
Google Scholar
Abd Rahim MA, Johani FH, Shah SA, Hassan MR, Abdul Manaf MR. (13)C-Urea breath test accuracy for Helicobacter pylori infection in the Asian population: A Meta-Analysis. Ann Glob Health. 2019;85(1):110.
Roy AD, Deuri S, Dutta UC. The diagnostic accuracy of rapid urease biopsy test compared to histopathology in implementing test and treat policy for Helicobacter pylori. Int J Appl Basic Med Res. 2016;6(1):18–22.
Google Scholar
Zangiabadian M, Ghorbani A, Nojookambari NY, Ahmadbeigi Y, Hosseini SS, Karimi-Yazdi M, Goudarzi M, Chirani AS, Nasiri MJ. Accuracy of diagnostic assays for the detection of clostridioides difficile: a systematic review and meta-analysis. J Microbiol Methods. 2023;204: 106657.
Google Scholar
Viprey VF, Clark E, Davies KA. Diagnosis of clostridioides difficile infection and impact of testing. J Med Microbiol. 2024;73(12):001939.
Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9.
Google Scholar
Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, Smith SI, Suerbaum S. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1): 19.
Google Scholar
Zhou J, Zhu J, Zhang P, Tao C, Hong X, Zhang Z. Global, regional, and national burdens of clostridioides difficile infection over recent decades: a trend analysis informed by the global burden of disease study. Microbiol Spectr. 2025;13(6):e0129024.
Google Scholar
Xia J, Liu T, Wan R, Zhang J, Fu Q. Global burden and trends of the clostridioides difficile infection-associated diseases from 1990 to 2021: an observational trend study. Ann Med. 2025;57(1): 2451762.
Google Scholar
Iino C, Shimoyama T, Chinda D, Sakuraba H, Fukuda S, Nakaji S. Influence of Helicobacter pylori infection and atrophic gastritis on the gut microbiota in a Japanese population. Digestion. 2020;101(4):422–32.
Google Scholar
He C, Peng C, Wang H, Ouyang Y, Zhu Z, Shu X, Zhu Y, Lu N. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults. Helicobacter. 2019;24(4): e12590.
Google Scholar
Sun M, Chen H, Dong S, Zhang G, Zhou X, Cheng H. Alteration of gut microbiota in post-stroke depression patients with Helicobacter pylori infection. Neurobiol Dis. 2024;193: 106458.
Google Scholar
Martín-Núñez GM, Cornejo-Pareja I, Coin-Aragüez L, Roca-Rodríguez MDM, Muñoz-Garach A, Clemente-Postigo M, Cardona F, Moreno-Indias I, Tinahones FJ. H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota. PLoS One. 2019;14(3): e0213548.
Google Scholar
Cui S, Liu X, Han F, Zhang L, Bu J, Wu S, Wang J. Helicobacter pylori CagA + strains modulate colorectal pathology by regulating intestinal flora. BMC Gastroenterol. 2025;25(1): 54.
Google Scholar
Wang Y, Zhou K, Zhang Y, Li C, Zhang Y, Ren X, Mi C, Ma L, Duan Y, Liu M, et al. The systemic impact of Helicobacter pylori infection on the microbiome of whole digestive tract based on mucosal, gastric juice, and fecal specimens. Helicobacter. 2025;30(3): e70047.
Google Scholar
Natarajan N, Pluznick JL. From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology. Am J Physiol Cell Physiol. 2014;307(11):C979–985.
Google Scholar
Hryckowian AJ, Van Treuren W, Smits SA, Davis NM, Gardner JO, Bouley DM, Sonnenburg JL. Microbiota-accessible carbohydrates suppress clostridium difficile infection in a murine model. Nat Microbiol. 2018;3(6):662–9.
Google Scholar
Pensinger DA, Dobrila HA, Stevenson DM, Hryckowian ND, Amador-Noguez D, Hryckowian AJ. Exogenous butyrate inhibits butyrogenic metabolism and alters virulence phenotypes in clostridioides difficile. mBio. 2024;15(3): e0253523.
Google Scholar
Seekatz AM, Theriot CM, Rao K, Chang YM, Freeman AE, Kao JY, Young VB. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent clostridium difficile infection. Anaerobe. 2018;53:64–73.
Google Scholar
Pensinger DA, Fisher AT, Dobrila HA, Van Treuren W, Gardner JO, Higginbottom SK, Carter MM, Schumann B, Bertozzi CR, Anikst V, et al. Butyrate differentiates permissiveness to clostridioides difficile infection and influences growth of diverse C. difficile isolates. Infect Immun. 2023;91(2):e0057022.
Google Scholar
Ouyang ZR, Niu XR, Wang WG, Zhao JH. The role of short-chain fatty acids in clostridioides difficile infection: a review. Anaerobe. 2022;75: 102585.
Google Scholar
Fachi JL, Sécca C, Rodrigues PB, Mato FCP, Di Luccia B, Felipe JS, Pral LP, Rungue M, Rocha VM, Sato FT et al. Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2. J Exp Med. 2020;217(3):jem.20190489.
Herrera G, Castañeda S, Arboleda JC, Pérez-Jaramillo JE, Patarroyo MA, Ramírez JD, Muñoz M. Metagenome-assembled genomes (MAGs) suggest an acetate-driven protective role in gut microbiota disrupted by clostridioides difficile. Microbiol Res. 2024;285: 127739.
Google Scholar
Nei T, Hagiwara J, Takiguchi T, Yokobori S, Shiei K, Yokota H, Senoh M, Kato H. Fatal fulminant clostridioides difficile colitis caused by Helicobacter pylori eradication therapy; a case report. J Infect Chemother. 2020;26(3):305–8.
Google Scholar
Archimandritis A, Souyioultzis S, Katsorida M, Tzivras M. Clostridium difficile colitis associated with a ‘triple’ regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori. J Intern Med. 1998;243(3):251–3.
Google Scholar
Nawaz A, Mohammed I, Ahsan K, Karakurum A, Hadjiyane C, Pellecchia C. Clostridium difficile colitis associated with treatment of Helicobacter pylori infection. Am J Gastroenterol. 1998;93(7):1175–6.
Google Scholar
Castro-Fernández M, Marqués-Ruiz A, Cámara-Baena S, Grande-Santamaría L. Clostridium difficile infection associated with bismuth-based quadruple therapy (Pylera(®)) for Helicobacter pylori eradication. Gastroenterol Hepatol. 2019;42(7):459–60.
Google Scholar
Prieto de Paula JM, García Colodro J, Prieto Dehesa M, Franco Hidalgo S. Clostridium difficile infection associated with metronidazole-based treatment for Helicobacter pylori eradication. Gastroenterol Hepatol. 2019;42(8):524.
Google Scholar
Muhsen K, Na’amnih W, Adler A, Carmeli Y, Cohen D. Clostridium difficile-associated disease and Helicobacter pylori seroprevalence: a case-control study. Helicobacter. 2020;25(1):e12668.
Google Scholar
Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, Consolandi C, Quercia S, Scurti M, Monti D, et al. Gut microbiota and extreme longevity. Curr Biol. 2016;26(11):1480–5.
Google Scholar
Biragyn A, Ferrucci L. Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging. Lancet Oncol. 2018;19(6):e295–304.
Google Scholar
Zeng T, Cui H, Tang D, Garside GB, Wang Y, Wu J, Tao Z, Zhang L, Tao S. Short-term dietary restriction in old mice rejuvenates the aging-induced structural imbalance of gut microbiota. Biogerontology. 2019;20(6):837–48.
Google Scholar
Ishanvi I, Patro S, Sharma V, Sandeep C, Mohapatra S, Sabat S, Panigrahi K, Pathi BK. Incidence and risk factors of clostridium difficile infection among adult patients admitted to the inpatient department of a tertiary care hospital: A Hospital-Based observational study. Cureus. 2024;16(12):e75071.
Google Scholar
Segar L, Easow JM, Srirangaraj S, Hanifah M, Joseph NM, Seetha KS. Prevalence of clostridium difficile infection among the patients attending a tertiary care teaching hospital. Indian J Pathol Microbiol. 2017;60(2):221–5.
Google Scholar
Mana F, Van Laer W, Bossuyt A, Urbain D. The early effect of proton pump inhibitor therapy on the accuracy of the 13 C-urea breath test. Dig Liver Dis. 2005;37(1):28–32.
Google Scholar
Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS, El-Zimaity HM. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol. 2003;98(5):1005–9.
Google Scholar
Lawes T, Lopez-Lozano JM, Nebot CA, Macartney G, Subbarao-Sharma R, Wares KD, Sinclair C, Gould IM. Effect of a National 4 C antibiotic stewardship intervention on the clinical and molecular epidemiology of clostridium difficile infections in a region of scotland: a non-linear time-series analysis. Lancet Infect Dis. 2017;17(2):194–206.
Google Scholar
Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of clostridium difficile infection. JAMA Intern Med. 2015;175(4):626–33.
Google Scholar
Brown KA, Langford B, Schwartz KL, Diong C, Garber G, Daneman N. Antibiotic prescribing choices and their comparative C. difficile infection risks: a longitudinal case-cohort study. Clin Infect Dis. 2021;72(5):836–44.
Google Scholar
Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S, Shah SC. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2024;119(9):1730–53.
Google Scholar
Bishop EJ, Tiruvoipati R. Management of clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines. J Antimicrob Chemother. 2022;78(1):21–30.
Google Scholar
Abboud Y, Richter B, Malhotra R, Vossough-Teehan S. Treating Helicobacter pylori and recurrent clostridioides difficile coinfection: a delicate balance in management and a need for guidelines. ACG Case Rep J. 2024;11(6): e01369.
Google Scholar
Shea KM, Hobbs ALV, Jaso TC, Bissett JD, Cruz CM, Douglass ET, Garey KW. Effect of a health care system respiratory fluoroquinolone restriction program to alter utilization and impact rates of clostridium difficile infection. Antimicrob Agents Chemother. 2017. https://doi.org/10.1128/AAC.00125-17.
Google Scholar
Scaria E, Barker AK, Alagoz O, Safdar N. Association of visitor contact precautions with estimated hospital-onset clostridioides difficile infection rates in acute care hospitals. JAMA Netw Open. 2021;4(2):e210361.
Google Scholar
Carling PC, O’Hara LM, Harris AD, Olmsted R. Mitigating hospital-onset clostridioides difficile: the impact of an optimized environmental hygiene program in eight hospitals. Infect Control Hosp Epidemiol. 2023;44(3):440–6.
Google Scholar